Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 36 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 13 | 531−10%/yr | −10%/yr | 2.30.9× | 19% | 900 in 2030+9.2%/yr |
| Lumbar fusion | 6 | 324−6.1%/yr | −6.1%/yr | 1.40.7× | 0% | 500 in 2030+7.7%/yr |
| Kyphoplasty & vertebroplasty | 2 | 210−1.5%/yr | −1.5%/yr | 0.91.1× | 9% | 240 in 2030+2%/yr |
| Cervical fusion & disc arthroplasty | 2 | 171−9.5%/yr | −9.5%/yr | 0.70.7× | 0% | 180 in 2030+0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 58 | 11,363−2.7%/yr | −2.7%/yr | 48.50.5× | 20% | 14,000 in 2030+3.5%/yr |
| Skin substitutes & wound grafts | 12 | 1,375+11%/yr | +11%/yr | 4.40.9× | 20% | 1,740 in 2030+4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 34 | 2,030+2.3%/yr | +2.3%/yr | 8.71.2× | 67% | 3,060 in 2030+7.1%/yr |
| Spinal cord & DRG stimulation | 2 | 101+2.3%/yr | +2.3%/yr | 0.41.1× | 46% | 190 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 5 | 534−11%/yr | −11%/yr | 2.30.4× | 0% | 1,240 in 2030+15%/yr |
| Dialysis access | 6 | 354−13%/yr | −13%/yr | 1.60.3× | 0% | 380 in 2030+1.2%/yr |
| Carotid revascularization | 4 | 267−3.3%/yr | −3.3%/yr | 1.21.2× | 0% | 360 in 2030+5.1%/yr |
| Thrombectomy, IVC filters & venous stents | 0 | 145−3.6%/yr | −3.6%/yr | 0.60.5× | 0% | 220 in 2030+7.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 13 | 1,120−0.6%/yr | −0.6%/yr | 5.20.9× | 2% | 1,720 in 2030+7.5%/yr |
| Cholecystectomy & appendectomy | 6 | 766−3%/yr | −3%/yr | 3.41.0× | 2% | 990 in 2030+4.4%/yr |
| Colorectal resection | 1 | 334−4.2%/yr | −4.2%/yr | 1.50.9× | 0% | 420 in 2030+3.9%/yr |
| Antireflux & hiatal hernia surgery | 1 | 142+1.5%/yr | +1.5%/yr | 0.61.0× | 0% | 220 in 2030+7.4%/yr |
| Bariatric surgery | 0 | 103−3.3%/yr | −3.3%/yr | 0.42.7× | 0% | 90 in 2030−2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 22 | 921−1.3%/yr | −1.3%/yr | 4.10.7× | 2% | 1,150 in 2030+3.8%/yr |
| BPH procedures | 11 | 730−2.7%/yr | −2.7%/yr | 3.20.7× | 25% | 880 in 2030+3.1%/yr |
| Hysterectomy, hysteroscopy & ablation | 3 | 531−0.4%/yr | −0.4%/yr | 2.50.7× | 6% | 910 in 2030+9.3%/yr |
| Incontinence, prolapse & sacral neuromodulation | 5 | 344−2.3%/yr | −2.3%/yr | 1.50.8× | 0% | 460 in 2030+4.9%/yr |
| Prostatectomy & nephrectomy | 5 | 194−3.3%/yr | −3.3%/yr | 0.90.8× | 0% | 300 in 2030+7.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 1 | 250−0.6%/yr | −0.6%/yr | 1.10.3× | 45% | 340 in 2030+5.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 20 | 1,151−0.9%/yr | −0.9%/yr | 5.30.6× | 19% | 1,410 in 2030+3.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 60 | 7,226+35%/yr | +35%/yr | 31.51.1× | 56% | 14,600 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 18 | 814−0.4%/yr | −0.4%/yr | 3.70.8× | 0% | 1,020 in 2030+3.7%/yr |
| EP ablation | 11 | 595+16%/yr | +16%/yr | 2.30.7× | 0% | 1,590 in 2030+18%/yr |
| LAA occlusion & loop recorders | 16 | 537+13%/yr | +13%/yr | 2.10.7× | 11% | 1,450 in 2030+18%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 25 | 1,180−3.6%/yr | −3.6%/yr | 4.50.9× | 0% | 1,640 in 2030+5.7%/yr |
| Structural heart (TAVR, TEER) | 24 | 582+6.7%/yr | +6.7%/yr | 2.31.3× | 0% | 1,340 in 2030+15%/yr |
| Mechanical circulatory support | 2 | 133+3.3%/yr | +3.3%/yr | 0.61.0× | 0% | 120 in 2030−1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 45 | 10,8700%/yr | 0%/yr | 47.31.0× | 79% | 12,900 in 2030+2.8%/yr |
| Vitreoretinal surgery | 3 | 201+0.6%/yr | +0.6%/yr | 0.90.5× | 89% | 290 in 2030+6.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 83 | 23,743−2%/yr | −2%/yr | 107.60.9× | 28% | 31,200 in 2030+4.7%/yr |
| ERCP & endoscopic ultrasound | 10 | 688+1.5%/yr | +1.5%/yr | 3.10.8× | 0% | 920 in 2030+5%/yr |
| Bronchoscopy & lung nodule | 8 | 422+0.3%/yr | +0.3%/yr | 1.90.6× | 0% | 790 in 2030+11%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.